NCT02227147 · Interventional trial
Evaluation of Efficacy of 20 µg/ml rhNGF New Formulation (With Anti-oxidant) in Patients With Stage 2 and 3 NK
Overall registry status Completed
Phase 2
Conditions Neurotrophic Keratitis
Delaware Valley sites
- Penn Eye Care Scheie Eye Institute · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory